Mumbai (Maharashtra) [India], January 17: As India grapples with a diabetes epidemic, Fitterfly, a leading ISO-13485 certified digital therapeutics company with clinically-proven programs, releases its comprehensive report, Reimagining Diabetes Care 2024 . This study showcases the data from the Fitterfly Diabetes prime program across 2023 and the critical role digital therapies now play in empowering people to effectively manage diabetes.
Mumbai (Maharashtra) [India], March 7 (ANI/PRNewswire): Fitterfly, a leading Indian health-tech company, working in the area of diabetes & metabolic health, recently showcased data from its Digital Therapeutics Technology platform at the 16th International Conference on Advanced Technologies and Treatments for Diabetes (ATTD 2023) in Berlin, Germany. Fitterfly is the one of the few Indian healthcare companies to have received this opportunity in the last 16 years, thereby putting the company's efforts in the area of DTx on the world map. Besides research studies, this year Fitterfly was the only Indian Digital Therapeutics company invited to exhibit at the Tech Fair Expo in the innovation segment. The purpose of the ATTD meeting is to highlight innovative technologies and treatments in diabetes management. It brings together developers of new technologies with diabetes professionals and caretakers, researchers, industries, startup companies, investors, reimbursement authorities
Health tech startup Fitterfly raises $3.1 M in pre-Series A round
21 April 2021 | News Funds will be primarily used for improving the solution to deliver better patient outcomes at scale and impacting a large number of people by creating better awareness and reach
Source credit: Shutterstock
Fitterfly, a Mumbai based health-tech startup working in the field of Digital Therapeutics (DTx) has raised $3.1 million (Rs 22.3 crore) in Pre-Series A round.
The raise was led by Fireside Ventures and also saw participation from 9Unicorns – the accelerator fund of Venture Catalysts, Venture Catalysts and a clutch of angel investors from India, the US and Singapore.
Opinions expressed by
You re reading Entrepreneur India, an international franchise of Entrepreneur Media.
Healthtech company Fitterfly working in the field of digital therapeutics (DTx) announced on Wednesday it has raised $3.1 million in a Pre-Series A round led by Fireside Ventures and also saw participation from 9Unicorns the accelerator fund of Venture Catalysts Venture Catalysts and a clutch of angel investors from India, the US, and Singapore.
Kanwaljit Singh, managing partner, Fireside Ventures also joins as a board member. Fireside is known for investing in startups like boAt, Mamaearth, Vahdam, Yogabar, etc., and helping them become strong consumer brands people love.